DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 103 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2017. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $232,000 | -18.0% | 31,704 | +2.5% | 0.13% | -25.4% |
Q4 2018 | $283,000 | +14.1% | 30,944 | +54.5% | 0.17% | +218.9% |
Q3 2018 | $248,000 | -69.4% | 20,023 | -45.7% | 0.05% | -55.1% |
Q3 2017 | $811,000 | +6.7% | 36,870 | -53.2% | 0.12% | +14.6% |
Q2 2017 | $760,000 | +8.6% | 78,774 | -33.0% | 0.10% | +10.8% |
Q1 2017 | $700,000 | +137.3% | 117,568 | +57.5% | 0.09% | +132.5% |
Q4 2016 | $295,000 | +23.9% | 74,639 | +189.6% | 0.04% | +11.1% |
Q3 2016 | $238,000 | -24.9% | 25,776 | +18.5% | 0.04% | -34.5% |
Q2 2016 | $317,000 | -14.6% | 21,753 | +12.7% | 0.06% | -14.1% |
Q1 2016 | $371,000 | +28.4% | 19,295 | +61.2% | 0.06% | +3.2% |
Q4 2015 | $289,000 | +5.5% | 11,966 | +7.1% | 0.06% | -36.7% |
Q3 2015 | $274,000 | – | 11,168 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
Maven Securities LTD | 264,989 | $931,000 | 0.29% |
Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |